EYELEAD trial

The EYELEAD trial is a clinical study designed to evaluate how effective a specific eye treatment is for patients with Age-related Macular Degeneration (AMD), a common cause of vision loss. Participants receive either the new treatment or standard care, and researchers compare outcomes to see if vision improves or stabilizes better with the new approach. The trial helps determine if the new treatment is safe and beneficial, potentially leading to improved options for managing AMD and preserving vision in affected individuals.